Answers are grounded in this paper and cite their sources.
Purpose Optimal treatment sequencing in malignant pleural mesothelioma (MPM) remains uncertain, particularly after progression on first-line (1L) treatment. We assessed real-world outcomes of patients receiving second-line (2L) carboplatin-pemetrexed (CARBO-PEM) after nivolumab-ipilimumab (NIVO-IPI), or 2L nivolumab (NIVO) after CARBO-PEM and explored the prognostic value of the Mesothelioma Risk Score (MRS) in the 1L setting. Materials and Methods This multicenter retrospective study included patients with advanced MPM treated across five UK institutions between May 2015 and November 2025. Eligible patients received either 2L CARBO-PEM after NIVO-IPI, or 1L CARBO-PEM followed by 2L NIVO. The primary end point was overall survival (OS) from 1L treatment initiation. Results Overall, 147 patients were included, and 54 received NIVO-IPI followed by CARBO-PEM and 93 received CARBO-PEM followed by NIVO. The median age was 73.8 years and 83.0% had epithelioid histology. The median follow-up was 43.3 months from 1L initiation. The median OS was 23.55 months with CARBO-PEM followed by NIVO versus 25.53 months with NIVO-IPI followed by CARBO-PEM (hazard ratio 1.28 [95% CI, 0.82 to 2.01]; P = .270). The median PFS 2L was 3.65 months with 2L NIVO versus 6.15 months with 2L CARBO-PEM, without statistical significance, while median OS 2L was 12.53 months and 14.11, respectively. In the 1L setting, MRS showed limited discrimination for PFS and OS. Grade ≥2 irAEs during NIVO-IPI were associated with longer PFS 1L but not OS. Conclusion In patients with MPM receiving 2L therapy, CARBO-PEM after NIVO-IPI remains clinically active, and OS appeared similar across treatment sequences. These findings support sequence flexibility in fit patients but highlight the need for more robust prognostic biomarkers.
No takes yet. Share an insight, caveat, or question.
Maffezzoli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: